secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001193125-24-064380
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed prices $175M combined offering of common shares at $6.00 each
---------------------------------------------------------------------

- Underwritten offering of 16,666,667 common shares at $6.00 per share with net proceeds of ~$93.8M.
- Concurrent private placement of 12,500,000 common shares at $6.00 per share to Deep Track Capital and Commodore Capital, net proceeds ~$70.3M.
- Combined gross proceeds expected to be ~$175M; closing expected on March 11, 2024.
- Proceeds will be used for R&D of product candidates, working capital, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000119312524064380/0001193125-24-064380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000119312524064380/d787577d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-064380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer